- Home
- ARWR vs ASTH Comparison
ARWR vs ASTH Comparison
Compare ARWR & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | ASTH |
|---|---|---|
| Founded | 2003 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 1.9B |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ARWR | ASTH |
|---|---|---|
| Price | $66.52 | $34.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $83.40 | $34.86 |
| AVG Volume (30 Days) | ★ 1.6M | 287.8K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.80 | N/A |
| EPS | N/A | ★ 0.69 |
| Revenue | $16,142,321.00 | ★ $519,907,752.00 |
| Revenue This Year | N/A | $27.38 |
| Revenue Next Year | N/A | $10.78 |
| P/E Ratio | ★ N/A | $49.49 |
| Revenue Growth | N/A | ★ 45.90 |
| 52 Week Low | $30.77 | $18.08 |
| 52 Week High | $95.49 | $51.60 |
Technical Indicators
Market Signals| Indicator | ARWR | ASTH |
|---|---|---|
| Relative Strength Index (RSI) | 25.28 | 31.55 |
| Support Level | $60.60 | $20.57 |
| Resistance Level | $71.83 | $40.11 |
| Average True Range (ATR) | 4.01 | 1.74 |
| MACD | -2.24 | -0.39 |
| Stochastic Oscillator | 10.13 | 8.37 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.
About ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.